tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SUPN Stock Latest News

Supernus Revises Merger Milestone Payment Obligations Agreement
Company AnnouncementsSupernus Revises Merger Milestone Payment Obligations Agreement
6d ago
8K
SUPN
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
PremiumThe Fly
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
2M ago
ATAI
CYBN
Supernus price target raised to $55 from $50 at Stifel
PremiumThe Fly
Supernus price target raised to $55 from $50 at Stifel
2M ago
SUPN
Supernus Pharmaceuticals: Strategic Growth, Clinical Advances, and Strong Financial Synergies Drive Buy Rating
PremiumRatings
Supernus Pharmaceuticals: Strategic Growth, Clinical Advances, and Strong Financial Synergies Drive Buy Rating
2M ago
SUPN
Supernus management to meet virtually with Cantor Fitzgerald
PremiumThe Fly
Supernus management to meet virtually with Cantor Fitzgerald
2M ago
SUPN
Bank of America Highlights Five Stocks It Says Still Offer Clear Upside in 2025
PremiumMarket NewsBank of America Highlights Five Stocks It Says Still Offer Clear Upside in 2025
2M ago
CR
BAC
Supernus Pharmaceuticals’ Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Supernus Pharmaceuticals’ Earnings Call: Growth Amid Challenges
3M ago
SUPN
Supernus Pharmaceuticals Reports Strong Q3 2025 Growth
Premium
Company Announcements
Supernus Pharmaceuticals Reports Strong Q3 2025 Growth
3M ago
SUPN
Supernus Pharmaceuticals: Strong Product Performance and Strategic Management Drive Buy Rating
PremiumRatings
Supernus Pharmaceuticals: Strong Product Performance and Strategic Management Drive Buy Rating
3M ago
SUPN
Supernus reports Q3 EPS (80c) vs. 69c last year
PremiumThe Fly
Supernus reports Q3 EPS (80c) vs. 69c last year
3M ago
SUPN
Supernus raises FY25 revenue view to $685M-$705M from $670M-$700M
PremiumThe Fly
Supernus raises FY25 revenue view to $685M-$705M from $670M-$700M
3M ago
SUPN
Supernus Faces Supply Constraints Amid High ONAPGO Demand
PremiumCompany Announcements
Supernus Faces Supply Constraints Amid High ONAPGO Demand
3M ago
8K
SUPN
SUPN Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsSUPN Upcoming Earnings Report: What to Expect?
3M ago
SUPN
Skyworks upgraded, UnitedHealth downgraded: Wall Street’s top analyst calls
Premium
The Fly
Skyworks upgraded, UnitedHealth downgraded: Wall Street’s top analyst calls
3M ago
EW
SR
Supernus initiated with a Buy at BofA
Premium
The Fly
Supernus initiated with a Buy at BofA
3M ago
SUPN
Supernus Pharmaceuticals’ Real-World Study on ONAPGOTM: A Closer Look
PremiumCompany Announcements
Supernus Pharmaceuticals’ Real-World Study on ONAPGOTM: A Closer Look
3M ago
SUPN
Supernus Pharmaceuticals Advances ADHD Treatment Study in Young Children
PremiumCompany Announcements
Supernus Pharmaceuticals Advances ADHD Treatment Study in Young Children
3M ago
SUPN
Supernus Pharmaceuticals Advances SPN-817 Study for Seizure Treatment
PremiumCompany Announcements
Supernus Pharmaceuticals Advances SPN-817 Study for Seizure Treatment
3M ago
SUPN
Supernus Pharmaceuticals Advances with RENAISSANCE 2 Study on SPN-817
PremiumCompany Announcements
Supernus Pharmaceuticals Advances with RENAISSANCE 2 Study on SPN-817
3M ago
SUPN
Supernus price target raised to $60 from $45 at TD Cowen
PremiumThe FlySupernus price target raised to $60 from $45 at TD Cowen
3M ago
SUPN
Piper upgrades Supernus on ‘promising’ Onapgo trajectory
Premium
The Fly
Piper upgrades Supernus on ‘promising’ Onapgo trajectory
4M ago
SUPN
Supernus upgraded to Overweight from Neutral at Piper Sandler
Premium
The Fly
Supernus upgraded to Overweight from Neutral at Piper Sandler
4M ago
SUPN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >